Abstract
Malignant fungating wounds are a complication of cancer and develop in patients with advanced onset of the disease, typically within 6-12 months before death (Alexander, 2009). They can present in one of three different ways: as primary skin neoplasms, as local extension and integumentary erosion from primary tumours or malignancy recurrence, or as metastatic cutaneous lesions (Alexander, 2009). Malignant fungating wounds can develop from any type of malignancy but are mainly associated with breast cancer (66%) and head and neck tumours (24%). They can also develop in the groin, genitals and back (3%) or other sites (8%) (Tilley et al, 2021).
| Original language | English |
|---|---|
| Pages (from-to) | 28-32 |
| Number of pages | 5 |
| Journal | Wounds UK |
| Volume | 21 |
| Issue number | 3 |
| Publication status | Published - 25 Sept 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Dressing selection
- Fungating wounds
- Malignant wounds
- Palliative wound care
Fingerprint
Dive into the research topics of 'Complexities of conducting dressing selection research for malodourous fungating wounds'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver